HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by OLD National Bancorp IN

OLD National Bancorp IN grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 28.5% during the 4th quarter, HoldingsChannel reports. The firm owned 997 shares of the company’s stock after buying an additional 221 shares during the quarter. OLD National Bancorp IN’s holdings in HCA Healthcare were worth $299,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in the company. Terra Nova Asset Management LLC grew its position in shares of HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after buying an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its position in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after acquiring an additional 29 shares in the last quarter. Waldron Private Wealth LLC increased its stake in HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management lifted its position in HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after acquiring an additional 30 shares during the last quarter. Finally, UMB Bank n.a. grew its stake in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

NYSE HCA opened at $330.24 on Monday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market capitalization of $83.65 billion, a P/E ratio of 15.03, a PEG ratio of 1.12 and a beta of 1.64. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The business has a 50 day moving average price of $313.33 and a 200 day moving average price of $353.29.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the company posted $5.90 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.91 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a $0.72 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Analysts Set New Price Targets

HCA has been the topic of a number of research reports. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Oppenheimer upped their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays dropped their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Finally, KeyCorp dropped their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Activity at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.